FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> FDA | Wyeth | FDA approval | antidepressant

SPOTLIGHT: FDA OKs Wyeth's antidepressant Pristiq

Tools


Wyeth announced late Friday that it won FDA approval for Pristiq, its next-generation version of the antidepressant Effexor. Wyeth was looking for an approval of Pristiq to offset the considerable losses that are likely to follow Effexor's loss of patent protection in 2010. Report

Twitter   Facebook   LinkedIn   StumbleUpon  
Get Your FREE FiercePharma Email Newsletter:
Be the first to comment
More stories about FDA   Wyeth   FDA approval   antidepressant  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.